JNPMEDI Partners
Overview
JNPMEDI Partners is a South Korean investment firm and global accelerator that specializes in the pharmaceutical, biotechnology, and medical device sectors by providing direct investment, investor matching, and comprehensive business development solutions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| DDH Co., Ltd. | Apr 2026 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is JNPMEDI Partners based?
JNPMEDI Partners is headquartered in Incheon, South Korea.
When was JNPMEDI Partners founded?
JNPMEDI Partners was founded in 2025.
How many portfolio companies does JNPMEDI Partners have?
JNPMEDI Partners has 1 portfolio company in Caplight's dataset.
What are some companies in JNPMEDI Partners's portfolio?
Portfolio companies visible on Caplight include DDH Co., Ltd..
What was JNPMEDI Partners's most recent investment shown here?
JNPMEDI Partners's most recent investment in this portfolio sample was in DDH Co., Ltd. in 2026.
What sectors does JNPMEDI Partners focus on?
JNPMEDI Partners focuses on Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does JNPMEDI Partners focus on?
JNPMEDI Partners typically invests at the Mid stage.